Aquatic Capital Management’s Arcturus Therapeutics ARCT Stock Holding History

Aquatic Capital Management’s Portfolio ARCT Stock Details ARCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-3,300	Closed	-$76.6K	–	1319
2024 Q3	$76.6K	Sell	3,300 -27,700	-89%	-$593K	﹤0.01%	950
2024 Q2	$755K	Buy	31,000 +20,000	+182%	+$606K	0.03%	455
2024 Q1	$371K	Buy	11,000 +10,100	+1,122%	+$358K	0.01%	616
2023 Q4	$28K	Sell	900 -2,100	-70%	-$49.9K	﹤0.01%	1189
2023 Q3	$77K	Buy	3,000 +2,700	+900%	+$83.2K	﹤0.01%	872
2023 Q2	$9K	Sell	300 -2,000	-87%	-$54.4K	﹤0.01%	1206
2023 Q1	$55K	Sell	2,300 -11,500	-83%	-$206K	﹤0.01%	870
2022 Q4	$234K	Buy	+13,800	New	+$241K	0.02%	705

Other funds holding ARCT

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Aquatic Capital Management's ARCT Position: Q4 2024 in Review

Aquatic Capital Management sold out of Arcturus Therapeutics (ARCT) in Q4 2024, closing a stake of 3,300 shares — an estimated $76.6K sold.

Aquatic Capital Management first reported a position in ARCT in Q4 2022 and held it in 8 quarters. The position peaked at $755K in Q2 2024. 148 funds tracked by Wall St. Rank hold ARCT as of Q4 2024.

Aquatic Capital Management reported no remaining Arcturus Therapeutics position as of Q4 2024 after selling out during the quarter.
Aquatic Capital Management sold 3,300 Arcturus Therapeutics shares in Q4 2024, an estimated $76.6K.
Aquatic Capital Management first reported a position in Arcturus Therapeutics in Q4 2022 and held it in 8 quarters.
Aquatic Capital Management's Arcturus Therapeutics position peaked at $755K in Q2 2024.
148 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q4 2024.

Based on Aquatic Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.